Coeducation, said a new women's dorm would most likely be needed, ..... PHOTOS. CHILDREN. ANIMALS. Court decides in child's favor;. Gary hospital to pay $500,000. 2810 MISHAWAKA AVE. 232-9963. PHOTO COPY. AND. RESTORATION ..... Brooks of LaSalle and.
tally widened the scope of methodologies available to researchers interested in .... In their ERP guidelines report, Picton et al. (2000) ..... These procedures may transform the data into a form that is appropriate for more generic computations and
Nov 12, 2009 - of analyte identity should be on file and available to the Methods. Committee ..... mobile site must be validated under those or similar conditions.
Sep 24, 1982 - disseminated gonococcal infection, one Bartholinitis, three epididymitis, and one a rectal abcess. Patients without gonorrhoea. This included ...
Dr. Sam Sheppard was accused of beating his wife to death. - The show âThe Fugitiveâ was based on his life. He said he was asleep in the living room when his wife was attacked and the intruder knocked him unconscious. - It looked bad for him sinc
Radoslav Chayrov, Luchia Mukova, Angel Galabov, Ivanka Stankova. Amantadine and rimantadine analogues-synthesis and biological activity. 8. Boyka Stoykova, Maya Chochkova, Lubomira Nikolaeva-Glomb, Galya Ivanova,. Martin Å tÃcha, Tsenka Milkova. Ant
 D. H. Peregrine, Calculations of the development of an undular bore, J. Fluid Mech. 25, 321-330, (1966).  A. M. Wazwaz, The tanh and sine-cosine methods ...
(NPs) were not toxic, while medium size (i.e., 8, 12,. 17, 37 nm) induced severe sickness and loss of weight ... smaller than NPs synthesized at 100Â°C, with the most abundant population around 2-3 nm (Table 1). Particle ...... performed by the digit
Mar 23, 2007 - ISO/IEC International Standard 17025,. General requirements for the competence of testing and calibration laboratories. â¢ Help America Vote ...
example, then a child psychologist should be consulted (4). 3. .... dressings require change; the frequency should be a minimum of daily during exit-site infections. 4. ... management of dialysis at home;. â¢ arrangements at school re playing sports
formed to review macronutrients and food groups. ... Professor, Children's Nutrition Research Center, Depart- ... its Food Guide Pyramid food-intake patterns.
Jan 27, 2018 - OBSTETRICS & GYNECOLOGY. Guidelines for Diagnostic Imaging During Pregnancy ... a relevant clinical question or otherwise provide medical benefit to the patient. With few ..... Should a pregnant woman undergo multiple imaging studies .
The human startle response is a sensitive, noninvasive measure of central ... (1939) or Dodge's pendulum-photochronograph method (Go- .... generated to contain frequencies in the 20 Hz to 20 kHz range ..... With an orifice of 0.5â1 cm at a distance
Detection of specific antibody has a temporal but not a causal association. â¢ Positive or negative predictive value of result depends on the clinical picture and the.
May 11, 2017 - tested. In order to exclude atypical infection and neoplasia, the right groin was explored with an excisional lymph node biopsy. Two days post- operatively, the patient developed a wound haematoma requiring drainage. There was no demon
Department of Microbiology, Seth G.SMC and KEM Hospital, Parel, Mumbai, 400012, India. Abstract Congenital .... manual of tests for syphilis, Washington, DC: American ... Paniker's Text Book of Microbiology, University Press, 9th edition.
Oct 22, 2017 - paper. Plasma containing haemolysins agglutinates the test cells because of the anticomplementary nature of the citrate and the bromelin.
We investigate whether audit committee members of the board prove to be better ... placed simultaneously on the audit, remuneration and nomination ..... form: H1: Ceteris paribus, a firm with an overlap of audit committee and compensation.
Jan 1, 2017 - cytial virus (RSV), human metapneumovirus (HMPV), parainfluenza virus 1 to 3 (PIV1,. PIV2, and PIV3), and adenovirus (AdV) infections.
where RPR titres reported on a single serum ranged from 1 to 128. (Table 1). ... these assays to automated platforms have meant that these immunoassays are ...
Sep 28, 2014 - It was determined that the group had a low education level and did not have any ... We concluded that annual health check, vaccination and ...
Tryfon Vainas, MD; Harrie A.J.M. Kurvers, MD, PhD; Werner H. Mess, MD; Rick de ... Correspondence to Tryfon Vainas, MD, Department of Surgery, Maastricht ...
of brucellosis among abattoir workers of Lahore District and to determine the association of brucellosis with ..... neighbouring country India has reported many.
International Commission on Trichinellosis: Recommendations on the Use of Serological Tests for the Detection of Trichinella Infection in Animals and Man
Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di
Sanità, Rome, Italy 3
Department of Experimental Pathology, B.M.I.E., University of Pisa, Pisa, Italy
Federal Institute for Risk Assessment, Berlin, Germany
Danish Centre for Experimental Parasitology, The Royal Veterinary and Agricultural
University, Fredriksberg C, Denmark 6
Centre for Animal Parasitology, Agriculture and Agri-Food Canada, Saskatoon S7N2R3,
Summary The use of serological tests to detect Trichinella infection in domestic and wild animals and in humans has not been standardised yet. This review provides an uniform set of recommendations for the development and use of serological tests to detect circulating antibodies in serum samples. The recommendations are based on the best scientific published information and on the unpublished data from laboratories with a great expertise in this field and represent the official position of the International Commission on Trichinellosis regarding acceptable methods and the evaluation of the sensitivity and specificity. These recommendations are subject to change as new scientific information becomes available.
Introduction According to the International Commission on Trichinellosis (ICT) (Gamble et al., 2000; www.med.unipi.it/ict/welcome.htm) indirect (serological) methods are not recommended for the testing of individual carcasses of food animals at slaughter. This recommendation is consistent with practical legislation of many governmental bodies, under which meat inspection programs for Trichinella in pork, horse and game meats are performed using direct methods including trichinoscopy and artificial digestion (see Gamble et al., 2000; Nöckler et al., 2000; European Commission, 2001). Legislation for inspection of meat and meat products for the presence of Trichinella includes direct tests only, which if performed properly, have the sensitivity and specificity sufficient to detect all carcasses with larval burdens > 1 per gram of meat, the minimum level of infection considered to be of public health concern. No serological methods should be included in legislation for meat inspection because these methods do not meet the required standards for protection of public health.
Although serological methods for detection of Trichinella infection are not considered to be suitable for the purpose of meat inspection, there are important uses for these tests including: 1) surveillance of infection and epidemiological investigations in animal populations, particularly where the prevalence is high; and, 2) presumptive or retrospective diagnosis and surveillance of human infection. Due to the various methods that have been employed for serological detection of Trichinella infection, the ICT has compiled a series of recommendations for the use and interpretation of these tests.
SEROLOGICAL METHODS TYPES OF ASSAYS Many types of serological assays have been, and continue to be, used for the detection of Trichinella infections in animals and man. For animals, serological assays include, but are not limited to: 1) indirect immunofluorescence assay (IFA) employing cryostat sections of infected rodent muscle, frozen sections of free muscle larvae or formalin fixed whole larvae; 2) immuno-electrotransfer blot assay (IETB), or western blot, using muscle larvae excretorysecretory products as antigen; 3) enzyme immunohistochemical technique (EIH) employing cryostat sections of infected rodent muscles (e.g., diaphragm) or frozen sections of free muscle larvae; and 4) enzyme-linked immunosorbent assay (ELISA) employing the excretory-secretory (ES) products of the muscle larvae (Gamble et al., 1983; 1988) or synthetic tyvelose as antigen (Gamble et al., 1997; Kapel and Gamble, 2000; Pozio et al., 2002a). For detection of human infection, indirect hemagglutination (IHA), bentonite flocculation, IFA, latex agglutination and the ELISA are the more commonly used tests, the last being the most sensitive (Murrell and Bruschi, 1994; Dupouy-Camet et al., 2002). Competitive inhibition assay (CIA) and IETB (Dupouy-Camet et al., 1988; Ivanoska et al., 1989; Homan et al., 1992; Pozio et al., 1993, 1997, 2002a; Owen et al., 2001; Pinelli et al., 2001) have also been used for the diagnosis of trichinellosis in humans. These tests are considered confirmatory tests, rather than primary screening tests.
The ELISA is the most commonly used method for the detection of Trichinella infection in both animals and man because it is economical, reliable, readily standardized and provides an acceptable balance of sensitivity and specificity. It is the only serological method recommended by the Office International des Epizooties (OIE, 2000) for testing domestic
pigs. For these reasons, the ELISA will be the primary focus of these recommendations. However, other types of tests can have practical applications; therefore, the principles for use of the ELISA (requirements for performance, suitability for particular species, etc.) should be points for consideration in selecting any serological test for detection of Trichinella infection. For the ELISA, and for any serological test, independent validation should be performed using sera from infected and Trichinella-free animals or humans representative of the local population where the test is being used. The cut-off value of the ELISA, for example, can change based on host genotype and exposure to antigens in the local environment and in food. These are important considerations when testing either animals or humans (Navarrete et al., 1989). Control positive and negative sera are required on every ELISA plate to assure the test is performing properly (OIE, 2002).
ANTIGENS In the 1970s somatic antigens prepared from whole body extracts of muscle larvae were used in the ELISA for detection of Trichinella antibodies in pigs (Ruitenberg et al., 1974; Ruitenberg and van Knapen, 1977). This crude larval extract, produced from first stage muscle larvae collected by artificial digestion, should not be used for serological tests of either animals or humans due to a high probability of cross-reactions with other pathogens. For example, cross-reactions occur with serum samples from humans infected with Loa loa, Toxocara sp., and Anisakis (J. Dupouy-Camet, personal communication; E. Pozio, unpublished data).
During the 1980s, the specificity of the ELISA was improved by utilizing excretory-secretory (ES) antigens obtained from the in vitro incubation of Trichinella muscle larvae (Gamble et
al., 1983). These antigens, originating from larval secretions, consist of a group of structurally related glycoproteins. Information regarding Trichinella antigens has been summarized by Appleton et al. (1991) and Ortega-Pierres et al. (1996). The predominant antigen epitope recognized by animals and humans infected with Trichinella spiralis, or any of the other species of Trichinella currently known, is the so-called TSL-1 group. TSL-1 antigens are found in the stichocyte cells and on the surface of the parasite’s cuticle; they are actively secreted by first-stage larvae in the muscle. These antigens are produced for diagnostic use by in vitro cultivation of isolated muscle larvae or by biochemical methods of recovery from this same parasite stage. Methods for the preparation of these antigens have been published (Gamble et al., 1983; Seawright et al., 1983; Grencis et al., 1986; OIE, 2000) and the reader is referred to these articles for a detailed description of the methods. As noted, the TSL-1 antigen epitopes recognized by antibodies in Trichinella-infected animals and humans are common to all encapsulated and non-encapsulated species (Appleton et al., 1991). Consequently, Trichinella antigen can be routinely prepared from T. spiralis muscle larvae, because this species is readily maintained in laboratory mice, and used for ELISA to detect infection with any Trichinella species.
TSL-1 antigens share a common carbohydrate epitope (tyvelose), which has been synthesized (Reason et al., 1994; Wisnewski et al., 1993). Synthetic tyvelose is available commercially (Safe-Path Laboratories, LLC, Carlsbad, CA), and has been evaluated in several research studies, where its performance compared favorably with ES antigens for testing humans, pigs and other animals (Gamble et al., 1997; Bruschi et al., 2001; Owen et al., 2001; Pozio et al., 2002a). The synthetic carbohydrate antigen offers the advantages of stability and standardization. It has been shown to provide greater specificity, in many species, but may
sacrifice sensitivity. Recent reports of possible cross-reactions obtained using the tyvelose antigen and evidence of tyvelose-containing glycans in other nematode eggs will necessitate further studies to better define its specificity (Dea-Ayuela et al., 2001; Pozio et al., 2002a).
REAGENTS Conjugates - Better specificity is obtained in the ELISA and IETB using a species-specific anti-IgG reagent as compared with a Protein A conjugate. It is strongly recommended that a species-specific anti-IgG reagent be used even if it is necessary to have it custom made.
SAMPLE COLLECTION Serum is the preferred sample for conducting serological tests for Trichinella. Other samples that have been used include plasma, whole blood, and tissue fluids (Gamble and Patrascu, 1996). After collection, blood samples should be clotted and the sera frozen at –20°C as soon as possible; samples frozen at –20°C may be used for several months. It is important to avoid repeated freezing and thawing of samples, since serum titers will decline as a result; therefore, samples that will be used frequently should be made into aliquots. For periods of storage greater than 3 months, serum samples should be frozen at –80°C or lyophilized. If freezing is not possible, 1% merthiolate, or another suitable preservative, should be added to each serum sample at a dilution of 1:10,000.
Another alternative method for sample collection and storage is blood spots on filter paper (Owen et al., 2001). This method is useful when there are no facilities to collect blood using a syringe; blood spots may be stored at room temperature.
For tests performed using animal carcasses, where blood or serum is not available, tissue fluids or meat juice samples are an alternative. Several studies have reported on the use of tissue fluids for detection of Trichinella infection (Gamble and Patrascu, 1996; Kapel et al., 1998). Generally samples of tissue fluids are used at a lower dilution (higher concentration) in serological assays. If meat samples are used for the extraction of tissue fluids it is recommended to wash the tissue, cut it into small pieces, freeze and thaw it and use these new extracts instead of muscle fluids found in an original sampling, which is often mixed with blood and/or other surface contaminants.
VALIDATION AND QUALITY CONTROL An acceptable serological assay is one that is properly standardized and validated for its intended purpose. All components of the test that are critical for maintaining suitable performance (critical control points) should be identified and appropriately controlled, and the test should be conducted within a laboratory quality system (Gajadhar and Forbes, 2002; OIE, 2002). In particular, each batch or lot of antigen should be checked by checkerboard titration against a standardized positive control serum.
Commercially available serological tests such as the ELISA often must meet specific standards of sensitivity and specificity established by an individual country’s licensing authority. Users of commercial tests should verify that the test has been adequately evaluated using international reference standards and has received the approval of any relevant regulatory authorities. Commercial test kits that are not regulated often yield results that include high numbers of false positive (quite frequently) and false negative (less frequently) results. The user of any test should always conduct an independent evaluation of test
performance using panels of defined positive and negative sera that are representative of the population to be tested. The performance of the test relative to specificity and sensitivity should meet the purpose of the test.
When intended for use in epidemiological studies, the sensitivity and specificity of the ELISA, and other serological tests, must be considered when interpreting results. Estimates of sensitivity and specificity can be obtained by testing adequate numbers of known positive and known negative animals or humans. The negative control group should be representative of the local population and positives should represent various stages and levels of infection. For humans, blood donors often represent a good source of reference serum samples. The Office International des Epizooties (OIE, 2000) recommends a minimum of 300 known positive and 1000 known negative samples to establish sensitivity and specificity.
For a comprehensive discussion of requirements for the validation of a serological test, the reader is referred to the OIE (2000; 2002) (www.oie.int/eng/normes/mmanual/A_00013.htm).
RECOMMENDED USES SURVEILLANCE IN FOOD ANIMALS 1.
Swine Suitability of test The ELISA test, using ES or tyvelose antigens, is useful for surveillance systems to estimate the prevalence of infection in a domestic pig population. When possible, serologically positive animals should be examined by artificial digestion to confirm infection, to estimate the worm burdens, and to identify the species of Trichinella.
Artificial digestion using an appropriate amount of tissue (i.e., 100 grams or more) should be performed according to ICT Recommendations (Gamble et al., 2000; www.med.unipi.it/ict/welcome.htm). Serological methods, including the ELISA, should not be used for the detection of Trichinella infection in individual carcasses at the slaughterhouse, for the purpose of protecting human health.
Sensitivity and specificity In pigs, the sensitivity of the ELISA, using an ES antigen, has been reported to range from 93.1 – 99.2%, provided sufficient time has elapsed for infected animals to develop an antibody response (see Interpretation of Results, below). The specificity of the ES ELISA in pigs has been reported to range from 90.6 – 99.4% (Murrell et al., 1986; Oliver et al., 1989; van der Leek et al., 1992). Infections of as few as 1 larva per 100 g of tissue can be detected by ELISA (Gamble et al., 1983; Kapel and Gamble, 2000).
The use of a somatic extract of Trichinella (e.g., Melcher’s antigen) in the ELISA results in false positive reactions with sera from pigs infected with other parasites and/or microbes. Several studies have demonstrated that both ES and tyvelose antigens reduce cross-reactions that occur when using a crude Trichinella antigen in the ELISA (Gamble et al., 1983; 1988; 1997). The quality of ES antigen depends on adhering to proper methods for the cultivation of Trichinella muscle larvae and proper purification of the antigen (Gamble et al., 1988).
Methodologies A general method for conducting an ELISA test in pigs is described in the OIE Manual of Standards for Diagnostic Tests and Vaccines (Chapter 2.2.9) (Gamble, 2000) (www.oie.int/eng/normes/mmanual/A_00013.htm).
By special arrangements, standard antigens, reference sera and scientific consultation can be obtained from ICT members’ laboratories (www.med.unipi.it/ict/welcome.htm) and the OIE Reference Laboratories (www.oie.int/eng/oie/organisation/en_listeLR.htm).
Interpretation of results The level of infection of pigs with Trichinella larvae (worm burden) is directly correlated with the time required for antibodies to appear in the blood. For light infections (< 1 larva per gram of tissue), antibodies might not be detected by ELISA for 4-7 weeks or more following exposure (Gamble et al., 1983; Gamble, 1996, 1998), while antibodies might be detected from 2.5-3 weeks in pigs with higher numbers of muscle larvae (Smith and Snowdon, 1989; Kapel and Gamble, 2000). Thus, there is a risk of obtaining false-negative results during the early stages of infection, and for this reason, the ELISA and other tests measuring a serological response cannot be used for individual carcass testing.
On the other hand, there is no correlation between the ultimate worm burden (larvae per gram of tissue) and the result of the ELISA test once an animal has become
serologically positive. Therefore, artificial digestion of tissue is an important adjunct to ELISA to determine the public health risk associated with infected animals.
Trichinella antibodies may persist in pigs for a long time (Nöckler et al., 1995). It can be assumed that in slaughter pigs, which have a live weight of 90 to 100 kg at an age of 25 to 30 weeks, it is unlikely that a false-negative result will result from declining antibody titer (Nöckler et al., 2000).
Horses Suitability of the test Studies in horses have shown that serological responses to Trichinella infection in this species are less consistent than responses observed in pigs, rodents and humans (Smith and Snowdon, 1987; van Knapen et al., 1987; Polidori et al., 1989; Soule et al., 1989; Gamble et al., 1996; Voigt et al., 1997; Yepez-Mulia et al., 1999; SofronicMilosavjevic et al., 2001; Pozio et al., 2002a). Studies in horses experimentally infected with 5,000 Trichinella spiralis larvae reported a decline in antibody titer at week 15 post-infection, at which time infective larvae were still present in the muscle tissue (Voigt et al., 1997).
Low specificity with ES antigen and tyvelose antigen and low sensitivity due to a decreasing antibody titer, even in the presence of high numbers of larvae in the musculature, have been reported using ELISA and IETB (Soule et al., 1989; Pozio et al., 1997, 2002a).
Considering the present state of knowledge, the ICT cannot recommend serological methods for use in horses either for detection of single infections or for reliable surveillance. However, further studies are needed, especially in endemic regions, to determine if serological methods might have some value.
Special considerations A recent report (Pozio et al., 2002a) suggested the possibility that Trichinella has antigens in common with some plant parasitic nematodes, including tyvelose, which is believed to be highly specific (Spiegel and McClure, 1995; Lopez de Mendoza et al., 1999). If this report is substantiated in further studies, it will pose further problems for serological detection of Trichinella infection in the horse and more generally in herbivores.
Game and other animals intended for human consumption Suitability of the test Relatively few studies have used serological methods for estimating Trichinella infection in game animals intended for human consumption. There have been a few field studies estimating Trichinella infection in wild boars using an ES antigen in an ELISA. From the Netherlands, 31 of 458 samples (6.8%) were positive (van der Giessen et al., 2001) and from Germany, 234 of 16,888 samples were positive, corresponding with a seropositivity of 1.4% (Nöckler et al., 1999). This seroprevalence is much higher (up to 100 times) when compared with the prevalence of Trichinella in wild boars as determined by artificial digestion (between 0.001 and 0.01 % in Germany). These findings might be interpreted as resulting from the higher
sensitivity of the ELISA or a lower specificity of the ELISA due to cross-reactions. Based on these aforementioned studies, insufficient information is available on the performance of the ELISA in game animals to recommend this method for individual carcass inspection or for epidemiological studies for the purpose of estimating true prevalence. Further studies are required to determine the influence of cross-reactions and quality of blood samples on the specificity of the ELISA and also to determine whether very low level infections may be responsible for some of the positive serological results obtained.
Game animals intended for human consumption should be examined by artificial digestion, according to approved methods (Gamble et al., 2000; www.med.unipi.it/ict/welcome.htm).
SURVEILLANCE IN OTHER ANIMAL SPECIES Suitability of the test Due to the high number of parasitic, bacterial, fungal and viral infections, which can be present in wildlife, the risk of cross-reactions with non-specific antibodies is very high. Therefore, the use of serological methods for determining prevalence of Trichinella infection in wildlife must be preceded by a thorough evaluation of test sensitivity and specificity in the species and population being tested. The ICT discourages the use of serological methods for the detection and surveillance of Trichinella infection in wildlife, without such an evaluation. Any evaluation should include digestion of a minimum of 100 grams of tissue.
It is likely that some reports of serologically positive animals are the result of false positive reactions. This caution on the use of serological methods for testing wild animals is suggested by studies that reported a high serological prevalence for Trichinella in animals without larvae in muscles from regions where Trichinella infection was never observed (Vercammen et al., 2002) or the prevalence rate detected by artificial digestion was 100 times lower than that recorded using serological methods (Nöckler and Voigt, 1997a; Wacker et al., 1999). However, the much greater sensitivity of ELISA might also be a factor when testing wildlife populations where worm burdens may be very low (only a few larvae per kilogram of tissue). Additional studies are required to assess the occurrence of false positive reactions and the detection of very low level infections by serological methods in wildlife populations. To assure prevention of human disease, any meat-eating game animals intended for human consumption should be examined by tissue digestion.
Sensitivity and specificity Sensitivity and specificity should be determined by testing panels of sera from a sufficient number of known positive and known negative animals representing the species and population, prior to using a test. Since this is often not possible with wildlife species, the limitations should be clearly understood and explained when reporting or interpreting results.
1. Wild boar - In one study, an antibody response was detectable by ELISA 3 to 4 weeks after experimental infection of wild boars with different encapsulated Trichinella species (Kapel, 2001), however, seroconversion was delayed in infections with non-encapsulated species. The antibody level remained stable in wild boars infected with T. spiralis, T. britovi and T. nelsoni, but the rapid decrease of antibodies directed against T. nativa and Trichinella T6 was apparently associated with the rapid disappearance of larvae.
A few epidemiological studies have used ES antigens for the evaluation of prevalence in wild boar populations (van der Giessen et al., 2001), but these prevalence results have in general been much higher as compared to results obtained by artificial digestion. In contrast, the experimental studies of Kapel (2001) have shown a good correlation between larval burden and antibody response. Such differences are probably related to cross reactions resulting from infection with other tissue-migrating nematodes (Toxocara, Ascaris, Spirura), but no studies have been conducted to evaluate this phenomenon in wild boar.
Bear - Several studies have reported the use of ELISA to detect infection in bears (Ursus arctos, Ursus americanus) (Zarnke et al., 1997; Nutter et al., 1998); however, confirmatory digestion testing did not correlate well with serological results. Better specificity in the ELISA can be obtained by using a customized anti-bear IgG reagent as compared with the Protein A conjugate in the ELISA test (Gamble H.R., unpublished data).
Fox - Experimental studies in silver foxes (Vulpes vulpes) showed that use of an ES antigen in an ELISA is a suitable method for serological detection of Trichinella infection in this species (Kapel, 2000). Specific antibodies were detectable in all foxes infected with 500 or 2000 larvae between 2 and 6 weeks post infection, and these antibodies persisted throughout the experiment (30 and 76 weeks post-infection) with mean larval recovery rate at post mortem ranging from 4.3 to 11.3 larvae per gram of tissue (Nöckler and Voigt, 1997b). Anti-dog-IgG peroxidase conjugate is suitable as an alternative to the species-specific anti-fox antibody system since there is a close phylogenetic relationship between foxes and dogs. Results from field studies demonstrated a 100 times higher Trichinella seroprevalence in the red fox population (7.7%) compared to a prevalence of 0.07% in foxes examined by artificial digestion (Wacker et al., 1999). As in wild boars the huge difference between seroprevalence and actual detection of parasites may be due, in part, to the higher sensitivity of ELISA (0.01 larvae per g) and the limited ability to detect muscle larvae in small samples of muscle tissue. It should be considered that the larval recovery rate in the majority of foxes might be very low, i.e. about or less than 0.1 larvae per g of musculature, as published by Enemark et al. (2000) and van der Giessen et al. (2001).
Special considerations The variability of collection methods for game meat samples often creates problems in conducting serological tests. Samples are frequently contaminated by bacteria or fungi, or they may be hemolysed; these problems can cause false positive results. Filtration of contaminated samples with a 0.22 µm filter is useful to reduce the background, but is not always entirely effective.
Interpretation of results False negative results have been observed in wild animals (e.g., foxes and wild boars) with long-term low-level infections with sylvatic species, (e.g., T. britovi) (Pozio E., unpublished data).
USE IN DIAGNOSIS OF HUMAN TRICHINELLOSIS
According to Ljungström (1983) there are three objectives in the immunodiagnosis of human trichinellosis: (a) recognizing the acute infection to allow early anthelminthic treatment; (b) making a retrospective diagnosis; and (c) adding information to the epidemiology of the infection.
Suitability of test Many serological tests are available for human diagnosis (Despommier, 1986; Murrell and Bruschi, 1994; Kociecka et al., 2001; Dupouy-Camet et al., 2002). These tests include, for example, ELISA, IFA, CIA, IETB and counterimmunoelectrophoresis (CIE). Diagnostic laboratories might use more than one test for screening; for example, screening by ELISA to detect the response against a soluble antigen and by IFA to detect antibodies that react with antigens on the larva’s cuticle. When a single preliminary serological test is positive, another test, such as an IETB or CIA might be performed for confirmation. As a general rule, however, the ELISA with ES or tyvelose antigen can be used as the primary diagnostic of choice to detect infections in humans.
Sensitivity and specificity Absolute sensitivity (100%) has been obtained in humans infected with T. spiralis by ELISA (measuring IgG) using both a crude larval extract or ES antigens (van Knapen et al., 1982, Bruschi et al., 2001). This high rate of sensitivity, observed 50 days after infection, declined to about 80% after two years. However, parasite-specific IgM was detected for up to 11 years after infection. Serological tests measuring other classes of antibodies (IgA, IgE) resulted on lower sensitivity rates (Murrell and Bruschi, 1994). The study of the humoral response against stage-specific antigens has not resulted in an improvement in serodiagnosis; however, the search for newborn larvae specific IgA has shown promise for use in detection of the early phase of the infection (more than 80% of positivity after three weeks of infection) (Mendez-Loredo et al., 2001).
The sensitivity of ELISA was reported to be higher with ES antigen than with tyvelose for detecting circulating antibodies early in the infection (E. Pozio, unpublished data). However, in another report, asymptomatic infections are detected using the tyvelose antigen (Owen et al., 2001). Additional comparative studies are needed with these two antigens. High sensitivity (up to 100%) was also obtained with other tests, including IFA (Pozio et al., 1988) and CIA (Ivanoska et al., 1989).
Specificity depends primarily on the type of antigen used and the cut-off value established. Using the ELISA (Engvall and Ljungström, 1975), ES antigens are preferable to crude extracts of T. spiralis muscle larvae, since the former resulted in a higher specificity. This is particularly important in regions where other human
helminth infections (e.g., Ascaris, Trichuris, filariae) are common and cross-reactions with these parasites could give false positive results (Au et al., 1983; Mahannop et al., 1995). In industrialized countries, the risk of cross-reactions using ES antigen is low, but cross-reactions do occur with human larval migrans of unknown species. In sera from Greenlanders, false-positive reactions were suspected to be due to infection with Anisakis or Pseudoterranova from ingestion of marine fish (C. Kapel, unpublished data).
The use of the synthetic tyvelose antigen in the ELISA has resulted in even greater specificity (Bruschi et al., 2001; Owen et al., 2001), although some exceptions have been noted (Dea-Ayuela et al., 2001). Further study on this synthetic antigen is required.
Western blots have shown promise for discriminating trichinellosis patients from patients with other helminth infection, although possible cross-reactions may occur with cases of anisakiasis (Yera et al., 2003) and schistosomiasis (Dupouy-Camet J., unpublished data).
Methodologies Indirect hemagglutination (IHA), bentonite flocculation (BFT), IFA, latex agglutination (LA), and ELISA are the more commonly used tests, the last being the most sensitive (Murrell and Bruschi, 1994; Kociecka, 2000). CIA (Ivanoska et al., 1989) and IETB (Dupouy-Camet et al., 1988; Pozio et al., 1993; Owen et al., 2001)
have also been used. The ELISA for human infection is performed essentially as described for pigs, with the substitution of an anti-human IgG reagent.
IFA can be carried out either using frozen sections of infected tissue (Ljungström, 1974) or formalin fixed whole larvae (Brzosko et al., 1965; Pozio et al., 1988), as antigens, the former being more sensitive. With this test, all relevant immunoglobulins can be detected. Cross-reactions with Trichinella antigens were observed in persons with autoimmune diseases (Robert et al., 1996). Persons reading the fluorescent sections should be aware that only sections with a uniform fluorescence should be considered as positive, whereas those, which show a non-uniform fluorescence along the cuticle, should be considered as false-positive. Counter staining with Evans Blue reduces false positive results and facilitates reading of slides (Boireau et al., 1997).
IETB can be used as a primary or confirmatory test and when ES antigens are used it is quite specific and useful for follow-up studies (Andrews et al., 1995). The presence of antibodies specific for the TSL-1 antigen family (40-70 kDa in the reduced form) should be considered diagnostic.
Interpretation of results For humans, as for animals, it is imperative to evaluate the cut-off value on the basis of a panel of serum samples (at least 100-200 sera), which are representative of the human population for which the test will be used. The human genotype, food habits and environmental characteristics can influence the background of a serological test. This preliminary evaluation should be done for both commercial kits and laboratory-
developed tests. It is also important that the cut-off value be confirmed, every time the antigen, reagents or materials (e.g., ELISA plate) are modified or substituted.
Antibody levels do not correlate with the severity or the clinical course of trichinellosis in humans (Murrell and Bruschi, 1994). Seroconversion usually occurs between the second and fifth week of infection and the time required for seroconversion is inversely correlated with the infective dose. Serum may remain positive up to 1 year or more (19 years has been reported) after the end of the acute phase of infection (Pozio et al., 1993). In T. britovi human infections, seroconversion has been documented up to two months post infection. Serological testing performed in a large outbreak of human trichinellosis due to T. nativa revealed a seropositive rate of 45% and 87% at 3-4 and 10-11 weeks post-infection among confirmed cases. However, seroconversion from acute to convalescent samples was 55% (Schellenberg et al., 2003).
An evaluation of the antibody kinetics in infected persons should be conducted every three months to follow the success of chemotherapy. In persons infected with T. britovi, circulating antibodies disappear (in about one half of patients) within six months and within three years all persons are seronegative (Pozio et al., 1993). In T. spiralis infected persons, who received a delayed or ineffective therapy, specific antibodies can be detected for years (Pozio et al., 2001), whereas in those who received effective treatment in the first two weeks after infection specific antibodies can disappear in a shorter period of time.
The IFA has proved to be the most reliable method for discriminating between patients with biopsy-confirmed infection and those patients suspected of exposure, but biopsy negative (Murrell and Bruschi, 1994). Due to the fact that IFA is based on cuticle surface antigens of muscle larvae, cross-reactions may occur with Onchocerca spp. and Schistosoma mansoni (Robert et al., 1996).
SPECIES IDENTIFICATION According to current taxonomy, the genus Trichinella is composed of eight distinct species, all of which can infect humans (Pozio E., 2001; Pozio et al., 2002b). Of these eight species, five have an encapsulated larva in host muscles and infect only mammals (T. spiralis, T. nativa, T. britovi, T. murrelli, and T. nelsoni) and three show non-encapsulated larvae in host muscles and infect both mammals and birds (T. pseudospiralis) or mammals and reptiles (T. papuae and T. zimbabwensis) (Pozio et al., 2004). Furthermore, other genotypes strictly related to the above reported species have been described. Specifically: Trichinella T6 is related to T. nativa, Trichinella T8 and Trichinella T9 are related to T. britovi (Pozio, 2001). All of these species and genotypes can be easily identified by a multiplex-PCR and PCRRFLP (Wu et al., 1999; Zarlenga et al., 1999; Pozio and La Rosa, 2003).
Serological methods cannot be used to differentiate species. Although minor differences in the immune response against different Trichinella species have been described (Pozio et al., 1993; Bruschi et al., 1999; Kapel and Gamble, 2000) these differences were generally related to the kinetics of the antibody response. The antibody response is dependent on the rate of production of newborn larvae, which is generally higher in T. spiralis as compared with other species.
Differences have been observed in ELISA optical density values or IETB patterns obtained using serum samples of animals (Kapel and Gamble, 2000; Kapel, 2001) and humans (Pozio et al., 1993) infected with a Trichinella species which is the same or different from that which was used to prepare the antigen. However, these differences are of limited value for diagnostic purposes.
CONCLUSIONS This guideline is based on the best scientific published information and on the unpublished data from laboratories with a great expertise in this field and represent the official position of the International Commission on Trichinellosis regarding acceptable methods and the evaluation of the sensitivity and specificity. These recommendations are subject to change as new scientific information becomes available.
ACKNOWLEDGEMENTS The International Commission on Trichinellosis is very grateful to P. Boireau, J. Dupouy-Camet, M.A. Gomez Morales, R. Ko, P. Lind, and K.D. Murrell, for their helpful suggestions.
REFERENCES ANDREWS J.R.H., BANDI C., POZIO E., GOMEZ-MORALES M.A., AINSWORTH R. & ABERNETHY D. Identification of Trichinella pseudospiralis from a human case using random amplified polymorphic DNA. American Journal of Tropical Medicine & Hygiene, 1995, 53, 185-188.
APPLETON J.A., BELL R.G., HOMAN W. & VAN KNAPEN F. Consensus on Trichinella spiralis antigens and antibodies. Parasitology Today, 1991, 7, 190-192. AU A.C.S., KO R.C., SIMON J.W., RIDELL N.J., WONG F.W.F. & TEMPLER M.J. Study of acute trichinosis in Ghurkas: Specificity and sensitivity of enzyme-linked immunosorbent assay for IgM and IgE antibodies to Trichinella larvae antigens in diagnosis. Transactions of the Royal Society of Tropical Medicine & Hygiene, 1983, 77, 412-415.
BOIREAU P., FABIEN J.F., LE GUERHIER F., VAYSSIER M., PERRET C. & SOULÉ C. Detailed antigenic analysis of Trichinella T5 and T1 using monoclonal antibodies. Ortega Pierres G., Gamble R., van Knapen F. & Wakelin D. (Eds.) Trichinellosis. Germar Press, Nonoalco Tlateloco, Mexico, 211-217, 1997.
BRUSCHI F., POZIO E., WATANABE N., GOMEZ MORALES M.A., ITO M., HUANG Y. & BINAGHI R. Anaphylactic response to parasite antigens: IgE and IgG1 independently induce death in Trichinella-infected mice. International Archives of Allergy and Immunology, 1999, 119, 291296.
BRUSCHI F., MORETTI A., WASSOM D. & PIERGILI-FIORETTI D. The use of a synthetic antigen for the serological diagnosis of human trichinellosis. Parasite, 2001, 8, S141-S143.
BRZOSKO W., GANCARZ Z. & NOWOSLAWSKI A. Immunofluorescence in the serological diagnosis of Trichinella spiralis infection. Experimental Medicine and Microbiology, 1965, 17, 355-365.
DEA-AYUELA M.A., ROMARIS F., UBEIRA F.M., RAMA-INIGUEZ S., MARTINEZ-FERNANDEZ A. & BOLAS F. Possible presence of common tyvelose-containing glycans in Trichinella L1 larvae and embryonated eggs of several helminths. Parasite, 2001, 8, S120-S122.
DUPOUY-CAMET J., BOUGNOUX R.E., ANCELLE T., FAGARD R. & LAPIERRE J. Antigenic characteristics of two strains of Trichinella spiralis isolated during the horsemeat-related outbreaks of 1985 in France. Parasitolology Research, 1988, 75, 79-80.
DUPOUY-CAMET J., KOCIECKA W., BRUSCHI F., BOLAS-FERNANDEZ F. & POZIO E. Opinion on the diagnosis and treatment of human trichinellosis. Expert Opinion on Pharmacotherapy, 2002, 3, 1117-1130.
ENGVALL E. & LJUNGSTRÖM I. Detection of human antibodies to Trichinella spiralis by enzyme-linked immunosorbent assay (ELISA). Acta Pathologica Microbiologica Scandinavica, 1975, 83, 231-237.
ENEMARK H.L., BJORN H., HENRIKSEN S.A. & NIELSEN B. Screening for infection of Trichinella in red fox (Vulpes vulpes) in Denmark. Veterinary Parasitology, 2000, 88, 229237.
EUROPEAN COMMISSION. Opinion of the Scientific Committee on Veterinary Measures relating to Public Health on trichinellosis, epidemiology, methods of detection and Trichinella-free pig production. Adopted on 21-22 November 2001 in Brussels.
GAJADHAR A.A. & FORBES L.B. An internationally recognized quality assurance system for diagnostic parasitology in animal health and food safety, with example data on trichinellosis. Veterinary Parasitology, 2002, 103, 133-140.
GAMBLE H.R. Detection of trichinellosis in pigs by artificial digestion and enzyme immunoassay. Journal of Food Protection, 1996, 59, 295-298.
GAMBLE, H.R. Sensitivity of artificial digestion and enzyme immunoassay methods for inspection of trichinellosis in pigs. Journal of Food Protection, 1998, 61, 339-343.
GAMBLE H.R., ANDERSON W.R., GRAHAM C.E. & MURRELL K.D. Diagnosis of swine trichinosis by enzyme-linked immunosorbent assay (ELISA) using an excretory-secretory antigen. Veterinary Parasitology, 1983, 13, 349-361.
GAMBLE H.R., BESSONOV A.S., CUPERLOVIC K., GAJADHAR A.A., KNAPEN F. VAN, NÖCKLER K., SCHENONE H. & ZHU X. International Commission on Trichinellosis: Recommendations on methods for the control of Trichinella in domestic and wild animals intended for human consumption. Veterinary Parasitology, 2000, 93, 393-408.
GAMBLE H.R. & PATRASCU I.V. Whole blood, serum and tissue fluids in an EIA for swine
trichinellosis. Journal of Food Protection, 1996, 59, 1213-1217.
GAMBLE H.R., RAPIC D., MARINCULIC A. & MURRELL K.D. Evaluation of excretory-secretory antigens for the serodiagnosis of swine trichinellosis. Veterinary Parasitology, 1988, 30, 131-137.
GAMBLE H.R., SOLOMON M.B. & GAJADHAR A.A. Detection methods for trichinellosis in horses. Journal of Food Protection, 1996, 59, 420-425.
GAMBLE H.R., WISNEWSKI N. & WASSOM D. Detection of trichinellosis in swine by enzyme immunoassay using a synthetic glycan antigen. American Journal of Veterinary Research, 1997, 58, 417-421.
GRENCIS R.K., CRAWFORD C., PRITCHARD D.I., BEHNKE J.M. & WAKELIN D. Immunization of mice with surface antigens from the muscle larvae of Trichinella spiralis. Parasite Immunology, 1986, 8, 587-596.
HOMAN, W.L., DERKSEN, A.C. & VAN KNAPEN, F. Identification of diagnostic antigens from Trichinella spiralis. Parasitology Research, 1992, 78, 112-119.
IVANOSKA D., CUPERLOVIC K., GAMBLE H.R. & MURRELL K.D. Comparative efficacy of antigen and antibody detection tests for human trichinellosis. Journal of Parasitolology, 1989, 75, 38-41.
KAPEL C.M.O. Host diversity and biological characteristics of the Trichinella genotypes and their effect on transmission. Veterinary Parasitology 2000, 93, 263-278.
KAPEL C.M.O. Sylvatic and domestic Trichinella spp. in wild boars; infectivity, muscle larvae distribution, and antibody response. Journal of Parasitology, 2001, 87, 309-314.
KAPEL C.M.O. & GAMBLE H.R. Infectivity, persistence, and antibody response to domestic and sylvatic Trichinella spp. in experimentally infected pigs. International Journal for Parasitology, 2000, 30, 215-221.
KAPEL, C.M.O., WEBSTER, P., LIND, P., POZIO, E., HENRIKSEN, S-AA., MURRELL, K.D. & NANSEN, P. Trichinella spiralis, Trichinella britovi and Trichinella nativa. Infectivity, muscle larvae distribution and antibody response after experimental infection of pigs. Parasitology Research 1998, 84, 264-271.
KOCIECKA W. Trichinellosis: human disease, diagnosis and treatment. Veterinary Parasitolology, 2000, 93, 365-383.
KOCIECKA W., BRUSCHI F., MARINI C., MROZEWIZ B. & PIELOK L. Clinical appraisal of patients and detection of serum antibodies by ELISA and CIA tests in late periods of Trichinella sp. invasion. Parasite, 2001, 8, S147-S151.
LJUNGSTRÖM I. Antibody response to Trichinella spiralis. Kim C. (Ed.) Trichinellosis. New York: Intext, 449-460, 1974.
LJUNGSTRÖM I. Immunodiagnosis in man. Campbell W.C. (Ed.) Trichinella and Trichinosis. New York, Plenum Press, 403-424, 1983.
LOPEZ DE MENDOZA M.E., CURTIS R.H.C. & GOWEN S. Identification and characterization of excreted-secreted products and surface coat antigens of animal and plant-parasitic nematodes. Parasitology, 1999, 118, 397-405.
MAHANNOP P., SETASUBAN P., MOKAROTE N., TAPCHAISRI P. & CHAICUMPA W. Immunodiagnosis of human trichinellosis and identification of specific antigen for Trichinella spiralis. International Journal for Parasitology, 1995, 25, 87-94.
MENDEZ-LOREDO B., MARTINEZ Y., ZAMORA R., CHAPA-RUIZ R. & SALINAS-TOBON R. Class specific antibody responses to newborn larva antigens during Trichinella spiralis human infection. Parasite, 2001, 8, 152-157.
MURRELL K.D. & BRUSCHI F. Clinical trichinellosis. Sun T. (Ed.) Progress in Clinical Parasitology. Boca Raton, Fla: CRC Press, 117-150, 1994.
MURRELL K.D., ANDERSON W.R., SCHAD G.A., HANBURY R.D., KAZACOS K.R., BROWN J. & GAMBLE H.R. Field evaluation of the ELISA test for swine trichinosis: efficacy of the excretory-secretory antigen. American Journal of Veterinary Research, 1986, 47, 1046-1049.
NAVARRETE I., SERRANO F., REINA D., MARTINEZ FERNANDEZ A., ALBARRAN E., HABELA M. & NIETO C. Standardization of the enzyme-linked immunosorbent assay for detection of swine trichinellosis. Tanner C.E., Martinez Fernandez A.R. & Bolas Fernandez F. (Eds.), Trichinellosis, Consejo Superior de Investigaciones Cientificas Press, Madrid, Spain, 223230, 1989.
NÖCKLER K., VOIGT W.P., PROTZ D., MIKO A. & ZIEDLER K. Intravitale Diagnostik der Trichinellose beim Schwein mit dem indirekten ELISA (Indirect ELISA for the diagnosis of trichinellosis in living pigs). Berliner and Münchener Tierärztliche Wochenschrift, 1995, 108, 167-174.
NÖCKLER K. & VOIGT W.P. Comparison of methods for the diagnosis of trichinellosis. Ortega-Pierres G., Gamble H.R., van Knapen F. & Wakelin D. (Eds.) Trichinellosis. Germar Press, Nonoalco Tlateloco, Mexico, 653-658, 1997a.
NÖCKLER K. & VOIGT W.P. Experimental Trichinella spiralis infection in the silver fox (Vulpes vulpes fulva). Ortega-Pierres G., Gamble H.R., van Knapen F. & Wakelin D. (Eds.) Trichinellosis. Germar Press, Nonoalco Tlateloco, Mexico, 319-323, 1997b.
NÖCKLER K., PALLY R., DEDEK J., VOIGT W.P., MIKO A. & SCHUSTER R. Untersuchungen zum Vorkommen von Trichinella spp. beim Schwarzwild in Mecklenburg-Vorpommern mit dem indirekten ELISA und der Verdauungsmethode (Investigations on Trichinella prevalence in wild boars in Mecklenburg-Vorpommern using indirect ELISA and digestion method). Tagungsband der DVG, Fachgruppe ”Parasitologie und parasitäre Krankheiten”, Thema:
Neuere Methoden und Ergebnisse zur Epidemiologie von Parasitosen, 10.-12.03.99 in Hannover, 102-112, 1999.
NÖCKLER K., POZIO E., VOIGT W.P. & HEIDRICH J.. Detection of Trichinella infection in food animals. Veterinary Parasitology, 2000, 93, 335-350.
NUTTER F.B., LEVINE J.F., STOSKOPF M.K., GAMBLE H.R. & DUBEY J.P. Seroprevalence of Toxoplasma gondii and Trichinella spiralis in North Carolina black bears (Ursus americanus). Journal of Parasitology, 1998, 84, 1048-1050.
OFFICE INTERNATIONAL DES EPIZOOTIES. Manual of standards for diagnostic tests and vaccines, Paris, France, 322-327, 2000.
OFFICE INTERNATIONAL DES EPIZOOTIES. Quality standards and guidelines for veterinary laboratories: Infectious diseases. Paris, France, 1-63, 2002.
OLIVER D.G., SINGH P., ALLISON D.E., MURRELL K.D. & GAMBLE H.R. Field evaluation of an enzyme immunoassay for detection of hogs in a high volume North Carolina abattoir. Tanner C.E. (Ed.) Trichinellosis. Consejo Superior de Investigaciones Cientificas Press, Madrid, Spain, 439-444, 1989.
ORTEGA-PIERRES M.G., YEPEZ-MULIA L., HOMAN W., GAMBLE H.R., LIM P., TAKAHASHI Y., WASSOM D.L. & APPLETON J.A. Workshop on a detailed characterization of Trichinella
spiralis antigens: A platform for future studies on antigens and antibodies to this parasite. Parasite Immunology, 1996, 18, 273-284.
OWEN I.L., POZIO E., TAMBURRINI A., DANAYA R.T., BRUSCHI F. & GOMEZ MORALES M.A. Focus of human trichinellosis in Papua New Guinea. American Journal of Tropical Medicine and Hygiene, 2001, 65, 553-557.
PINELLI, E., VAN DER LUGT, G., HOMAN, W., VAN DER GIESSEN, J., & KORTBEEK, L.M. Antigen recognition by IgG4 antibodies in human trichinellosis. Parasite, 2001, 8, S168S171.
POLIDORI G.A., GRAMENZI F., PIERGILI FIORETTI D., FERRI N., RANUCCI S., MORETTI A., SCACCHIA M., BELLELLI C. & BALDELLI B. Experimental trichinellosis in horses. Tanner C.E., Martinez-Fernandez A.R. and Bolas Fernandez F. (Eds.), Trichinellosis. Consejo Superior de Investigaciones Cientificas Press, Madrid, Spain, 268-274, 1989.
POZIO E. 2001. New patterns of Trichinella infections. Veterinary Parasitology, 2001, 98, 133-148.
POZIO E., CAPPELLI O., MARCHESI L., VALERI P. & ROSSI P. Third outbreak of trichinellosis caused by consumption of horse meat in Italy. Annales de Parasitologie Humaine et Comparee, 1988, 63, 48-53.
POZIO E., FOGGIN C.M., MARUCCI G., LA ROSA G., SACCHI L., CORONA S., ROSSI P. & MUKARATIRWA S.. Trichinella zimbabwensis n.sp. (Nematoda), a new non-encapsulated species from crocodiles (Crocodylus niloticus) in Zimbabwe also infecting mammals. International Journal for Parasitology, 2002b, 32, 1787-1799.
POZIO E. & LA ROSA G. PCR-derived methods for the identification of Trichinella parasites from animal and human samples. Methods in Molecular Biology, 2003, 216, 299-309.
POZIO E., MARUCCI G., CASULLI A., SACCHI L., MUKARATIRWA S., FOGGIN C.M. & LA ROSA G. Trichinella papuae and Trichinella zimbabwensis induce infection in experimentally infected varans, caimans, pythons and turtles. Parasitology, 2004, 128, 333-342.
POZIO E., SACCHINI D., SACCHI L., TAMBURRINI A. & ALBERICI F. Failure of mebendazole in treating Trichinella spiralis infection in humans at the stage of encapsulating larvae. Clinical Infection Diseases, 2001, 32, 638-642.
POZIO E., SOFRONIC-MILOSAVLJEVIC L., GOMEZ MORALES M.A., BOIREAU P. & NÖCKLER K.. Evaluation of ELISA and Western blot analyses using three antigens to detect anti-Trichinella IgG in horses. Veterinary Parasitology, 2002a, 108, 163-178.
POZIO E., TAMBURRINI A., SACCHI L., GOMEZ MORALES M.A., CORONA S., GOFFREDO E. & LA ROSA G. Detection of Trichinella spiralis in a horse during routine examination in Italy. International Journal for Parasitology, 1997, 27, 1613-1621.
POZIO E., VARESE P., GOMEZ MORALES M.A., CROPPO G.P., PELLICCIA D. & BRUSCHI F. Comparison of human trichinellosis caused by Trichinella spiralis and Trichinella britovi. American Journal of Tropical Medicine and Hygiene, 1993, 48, 568-575.
REASON A.J., ELLIS L.A., APPLETON J.A., WISNEWSKI N., GRIEVE R.B., MCNEIL M., WASSOM D.L., MORRIS H.R. & DELL A. Novel tyvelose-containing tri- and tetra-antennary N-glycans in the immunodominant antigens of the intracellular parasite Trichinella spiralis. Glycobiology, 1994, 4, 593-603.
ROBERT F., WEILL B., KASSIS N. & DUPOUY-CAMET J. Investigation of immunofluorescence cross-reaction against Trichinella spiralis by Western blot (Immunoblot) analysis. Clinical Diagnosis Laboratory Immunology, 1996, 3, 575-577.
RUITENBERG E.J. & VAN KNAPEN F. Enzyme-linked immunosorbent assay (ELISA) as a diagnostic method for Trichinella spiralis infections in pigs. Veterinary Parasitolology, 1977, 3, 317-326.
RUITENBERG E.J., STEERENBERG P.A., BROSI B.J. & BUYS J. Serodiagnosis of Trichinella spiralis infections in pigs by enzyme-linked immunosorbent assays. Bulletin of the World Health Organization, 1974, 51, 108-109.
SCHELLENBERG R.S., TAN B.J.K., IRVINE J.D., STOCKDALE D.R., GAJADHAR A.A., SERHIR B., BOTHA J., ARMSTRONG C.A., WOODS S.A., BLONDEAU J.M. & MCNAB T.L. An outbreak of
trichinellosis due to consumption of bear meat infected with Trichinella nativa, in 2 northern Saskatchewan communities. Journal of Infectious Diseases, 2003, 188, 835-843.
SEAWRIGHT G.L., DESPOMMIER D., ZIMMERMANN W. & ISENSTEIN R.S. Enzyme immunoassay for swine trichinellosis using antigens purified by immunoaffinity chromatography. American Journal of Tropical Medicine and Hygiene, 1983, 32, 1275-1284.
SMITH H.J. & SNOWDON K.E. Experimental Trichinella infections in Ponies. Canadian Journal of Veterinary Research, 1987, 51, 415-416.
SMITH H.J. & SNOWDON K.E. Comparative assessment of a double antibody enzyme immunoassay test kit and a triple antibody enzyme immunoassay for the diagnosis of Trichinella spiralis spiralis and Trichinella spiralis nativa. . Canadian Journal of Veterinary Research, 1989, 53, 497-499.
SPIEGEL Y. & MCCLURE M.A. The surface-coat of plant-parasitic nematodes -chemical composition, origin and biological role – a review. Journal of Nematology, 1995, 27, 127134.
SOFRONIC-MILOSAVLJEVIC LJ., POZIO E., PATRASCU I.V., SKEROVIC N., GOMEZ MORALES M.A. & GAMBLE H.R.. Immunodiagnosis of Trichinella infection in the horse. Parasite, 2001, 8, 260-262.
SOULÉ C., DUPOUY-CAMET J., GEORGES P., ANCELLE T., GILLET J.P., VAISSAIRE J., DELVIGNE A. & PLATEAU E. Experimental trichinellosis in horses: biological and parasitological evaluation. Veterinary Parasitology, 1989, 31, 19-36.
VAN DER LEEK M.L.,
DAME J.B., ADAMS C.L., GILLIS K.D. & LITTELL R.C. Evaluation of an
enzyme-linked immunosorbent assay for diagnosis of trichinellosis in swine. American Journal of Veterinary Research, 1992, 53, 877-882.
VAN DER GIESSEN J.W.B.,
ROMBOUT Y., VAN DER VEEN A. & POZIO E. Diagnosis and
Epidemiology of Trichinella infections in wildlife in the Netherlands. Parasite, 2001, 8, 103105.
VAN KNAPEN F.,
FRANCHIMONT J.M., HENDRIKX W.M. & EYSKER M. Experimental
Trichinella spiralis infection in two horses. Veterinary Archives, 1987, 31, 123-132.
VAN KNAPEN F.,
FRANCHIMONT J.M., VERDONK A.R., STUMPF J. & UDEUTSCH K. Detection
of specific immunoglobulins IgG, IgM, IgA, IgE) and total IgE levels in human trichinosis by means of the enzyme linked immunosorbent assay (ELISA). American Journal of Tropical Medicine and Hygiene, 1982, 31, 973-976.
VERCAMMEN F., VERVAEKE M., DORNY P., BRANDT J., BROCHIER B., GEERTS S. & VERHAGEN R. Survey for Trichinella spp. in red foxes (Vulpes vulpes) in Belgium. Veterinary Parasitology, 2002, 103, 83-88.
VOIGT W.P., NÖCKLER K., FREISCHEM B., HENRIKSEN S.A., VAN KNAPEN F., MARTINEZ FERNANDEZ A., PFEIFFER G., POZIO E., REUTER G., RING CH., SOULÉ C. & WEISS H. Detection of low levels of Trichinella spiralis in experimentally infected horses. OrtegaPierres G., Gamble H.R., van Knapen F. & Wakelin D. (Eds.), Trichinellosis. Germar Press, Nonoalco Tlateloco, Mexico, 629-634, 1997.
WACKER K., RODRIGUEZ E., GARATE T., GEUE L., TACKMANN K., SELHORST T., STAUBACH C. & CONRATHS F.J. Epidemiological analysis of Trichinella spiralis infections of foxes in Brandenburg, Germany. Epidemiology and Infection, 1999, 123, 139-147.
WISNEWSKI N., MCNEIL M., GRIEVE R.B. & WASSOM D.L. Characterization of novel fucosyland tyvelosyl-containing glycoconjugates from Trichinella spiralis muscle stage larvae. Molecular and Biochemical Parasitology, 1993, 61, 25-35.
WU Z., NAGANO I., POZIO E. & TAKAHASHI Y. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) for the identification of Trichinella isolates. Parasitology, 1999, 118, 211-218.
YERA H., ANDIVA S., PERRET C., LIMONNE D., BOIREAU P. & DUPOUY-CAMET J. Development and evaluation of a western blot kit for the diagnosis of human trichinellosis. Clinical Diagnosis and Laboratory Immunology, 2003, 10, 793-796.
YEPES-MULIA L., ARRIAGA C., VIVEROS N., ADAME A., BENITEZ E. & ORTEGA-PIERRES M.G. Detection of Trichinella infection in horses by ELISA and Western blot analysis. Veterinary Parasitolology, 1999, 81, 57-68.
ZARLENGA D.S., CHUTE M.B., MARTIN A. & KAPEL C.M. A multiplex PCR for unequivocal differentiation of all encapsulated and non-encapsulated genotypes of Trichinella. International Journal for Parasitology, 1999, 29, 1859-1867.
ZARNKE R.L., GAMBLE H.R., HECKERT R.A. & VER HOEF J. Serologic survey for Trichinella spp. in grizzly bears (Ursus arctos) from Alaska, 1973 to 1987. Journal of Wildlife Diseases, 1997, 33, 474-479.